ResMed, the #1 global producer of CPAP machines and masks to treat sleep apnea acquiresSomnoware, a U.S. leader in sleep and respiratory care diagnostics software. Financial details of the acquisition were not disclosed.
Somnoware software streamlines the processes of physicians and sleep labs for diagnosing and evaluating a patient’s sleep and respiratory care test results, ordering treatment equipment, setting up appointments, tracking therapy compliance, and electronically providing this information directly into a patient’s electronic health record.
As part of the acquisition, Somnoware will retain all staff and be integrated into ResMed’s Sleep & Respiratory Care business. Somnoware platform will remain an open platform to enable sleep labs, pulmonary function testing facilities, and physicians to view results from various testing solutions and help diagnosed patients get onto the treatment they need faster.
M&A: ResMed Acquires Somnoware to Expand Sleep Management Offerings
by Fred Pennic Leave a Comment
What You Should Know:
Scale Biosciences announces ScalePlex technology to simplify single cell genomics studies of any scale
Novel multiplexing technology enables seamless sample pooling facilitating cost-efficient single cell experiments for compound screening and translational research.
Lykos is optimistic about MDMA treatment after meeting with FDA
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
The head of the Catholic Health Association calls for healing of the broken medical system
In the wake of the tragic murder of UnitedHealthcare CEO Brian Thompson, all of us who serve in health care must take time to pause